Skip to main content
INNOVASSYNTH TECHNOLOGIES (INDIA) LIMITED logo

INNOVASSYNTH TECHNOLOGIES (INDIA) LIMITED — Investor Relations & Filings

Ticker · 533315 ISIN · INE690J01011 LEI · 64889290B7SS3AUGO414 BSE.NS Manufacturing
Open in API
Filings indexed 14 across all filing types
Latest filing 2026-05-31 Investor Presentation
Country IN India
Listing BSE.NS 533315

About INNOVASSYNTH TECHNOLOGIES (INDIA) LIMITED

https://www.innovassynth.com

Innovassynth Technologies (India) Limited is a Custom Research and Manufacturing Services (CRAMS) organization specializing in complex organic synthesis and process development. The company provides integrated solutions for the pharmaceutical, biotechnology, and life sciences sectors, focusing on the development and manufacture of high-quality nucleosides, phosphoramidites, and specialty chemicals. Its core competencies include the synthesis of protected nucleosides and reagents essential for DNA and RNA synthesis. Operating with advanced research and development facilities, the firm supports clients through the entire product lifecycle, from initial laboratory-scale research to large-scale commercial production. The organization is recognized for its technical expertise in multi-step synthesis and its commitment to maintaining rigorous quality standards in the production of critical intermediates and active ingredients.

Recent filings

Filing Released Lang Actions
Investor Presentation for the quarter and year ended March 31, 2026.
Investor Presentation Classification · 95% confidence The document is a slide deck titled “Investor Presentation Q4FY26” delivered on May 31, 2026 and addressed to the stock exchange, containing forward-looking disclaimers, executive summary, financial highlights including P&L and balance sheet, strategic growth, company overview, and capital market information. It is not a brief earnings release, nor a regulatory certification or proxy; it clearly constitutes a detailed presentation for investors. Therefore, it should be classified as an Investor Presentation.
2026-05-31 English
Newspaper publication of financial results for the quarter and year ended March 31, 2026.
Report Publication Announcement Classification · 90% confidence The document is a short compliance letter under Regulation 47 of SEBI LODR notifying the stock exchange that copies of the newspaper advertisement of the audited financial results for the quarter and year ended March 31, 2026 have been published and are enclosed. It does not present the full results itself but merely announces and attaches the advertisement. Under the “menu vs meal” rule, this is not the report itself but a publication announcement. Therefore, it best fits Report Publication Announcement (RPA).
2026-05-31 English
Annual Secretarial Compliance Report for the year ended March 31, 2026.
Regulatory Filings Classification · 90% confidence The document is an Annual Secretarial Compliance Report under Regulation 24A of SEBI LODR, consisting of an attestation by a Practicing Company Secretary confirming corporate compliance. It is not the company’s Annual Report, financial statements, or a shareholder meeting material. Rather, it is a regulatory compliance certificate filed with the stock exchange. This falls under general regulatory filings/officer certifications. Therefore, it is classified as RNS.
2026-05-30 English
Board comments on fine levied by the BSE Limited
Regulatory Filings Classification · 85% confidence The document is a disclosure letter from Innovassynth to BSE under SEBI (LODR) Regulations, informing about a notice and fine levied by the exchange, board review and corrective actions. It is a compliance/regulatory announcement rather than an actual financial report, management change, dividend or capital raising event. It falls under general regulatory filings or compliance announcements, making it best classified as RNS (Regulatory Filings).
2026-05-29 English
Financial Results for the quarter and year ending March 31, 2026.
Regulatory Filings Classification · 75% confidence The document is an intimation to the stock exchange under Regulation 30 of SEBI LODR, titled “Outcome of Meeting of Board of Directors,” and encloses the audited financial results for the quarter and year ended March 31, 2026 along with the independent auditor’s report. It is a regulatory announcement/disclosure of financial results rather than a full Annual Report (10-K) or an interim report designed for investors, and it is not merely notifying of a future report (RPA). Therefore it best fits the “Regulatory Filings” category (RNS) as a compliance filing under listing obligations.
2026-05-29 English
Outcome of Board meeting held on May 29, 2026, for approval of audited results and accounts for the quarter and year ended March 31, 2026
Audit Report / Information Classification · 82% confidence The document is an intimation under Regulation 30/33 of SEBI LODR that encloses the Audited Financial Results for Q4 and the year ended March 31, 2026, together with the Independent Auditor’s Report. It is not the company’s full Annual Report (10-K) and it goes beyond a brief earnings release by including the full audit opinion and financial statements. It therefore best fits the standalone Audit Report / Information category. FY 2026
2026-05-29 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.